6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
5m ago	Yapi ve Kredi Bankasi : Successful issuance of 500 million US$ perpetual Additional Tier 1 Capital Transaction
10m ago	Crown Castle Names Kris Hinson as Chief Commercial Officer and Mark Lennon as Chief Information Officer
15m ago	Hovnanian Enterprises Reports Fiscal 2026 Second Quarter Results
15m ago	LivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit
15m ago	KKR Sells CIRCOR Aerospace to Parker Hannifin for $2.55 Billion

About

31.25USD+0.04 +0.13%

Closed • Updated at 13:31 GMT+00:00

Market Cap$3.82B

P/E Ratio17.96

Volume2.36M

Beta0.42

RSI73.57

Gross Margin79.62%

Health TechnologyPharmaceuticals: Major

Catalyst Pharmaceuticals, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Catalyst Pharmaceuticals Reports First Quarter 2026 Financial Results

Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease

Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Hetero Labs Ltd.

Catalyst Pharmaceuticals to Report First Quarter 2026 Financial Results on May 11, 2026

Catalyst Pharmaceuticals to Showcase Real‑World Findings in Duchenne Muscular Dystrophy and Host Vamorolone-Focused Symposium at the 2026 MDA Clinical & Scientific Conference

Community Chat

Ask AI